[1]Jonasson G, Kiliaridis S,Gunnarsson R.Cervical thickness of the mandibular alveolar process and skeletal bone mineral density.Acta Odontol Scand.1999;57:155-161.
[2]Taguchi A, Suei Y, Ohtsuka M, et al.Relationship between bone mineral density and tooth loss in elderly Japanese women.Dentomaxillofac Radiol. 1999;28:219-223.
[3]Becker W, Hujoel PP, Becker BE, et al. Osteoporosis and implant failure: an exploratory case-control study.J Periodontol. 2000;71:625-631.
[4]Klemetti E, Vainio P,Kroger H. Craniomandibular disorders and skeletal mineral status.Cranio.1995;13:89-92.
[5][No authors listed].Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis. Prescrire Int. 2008;17:143.
[6]Oursler MJ, Osdoby P, Pyfferoen J, et al. Avian osteoclasts as estrogen target cells.Proc Natl Acad Sci USA. 1991;88:6613-7.
[7]Martin-Millan M, Almeida M,Ambrogini E, et al.The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.Mol Endocrinol. 2010;24:323-334.
[8]Tera Tde M, Prado RF, De Marco AC, et al.The RANK/ RANKL/ OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. Braz Oral Res. 2014 Jan-Feb;28(1). pii: S1806-83242014000100261.
[9]Srivastava S,Toraldo G,Weitzmann MN,et al.Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem.2001;276:8836-8340.
[10]Robinson LJ,Yaroslavskiy BB,Griswold RD,et al.Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6.Exp Cell Res.2009; 315: 1287-301.
[11]Hofbauer LC, Khosla S, Dunstan CR, et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.Endocrinology. 1999;140:4367-4370.
[12]Ammann P, Rizzoli R, Bonjour JP, et al. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency.J Clin Invest.1997; 99: 1699-1703.
[13]Kimble RB, Srivastava S, Ross FP, et al. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production.J Biol Chem.1996;271:28890-28897.
[14]Kimble RB, Vannice JL, Bloedow DC, et al. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.J Clin Invest. 1994;93:1959-1967.
[15]Manolagas SC,Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.N Engl J Med. 1995;332:305-311.
[16]Pacifici R, Brown C, Puscheck E, et al.Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.Proc Natl Acad Sci USA. 1991;88:5134-5138.
[17]Tanaka S, Takahashi N, Udagawa N, et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.J Clin Invest. 1993; 91:257-263.
[18]Kitazawa R, Kimble RB, Vannice JL, et al.Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.J Clin Invest. 1994;94:2397-2406.
[19]Charatcharoenwitthaya N, Khosla S, Atkinson EJ, et al. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women.J Bone Miner Res. 2007;22:724-729.
[20]Roggia C, Gao Y, Cenci S, et al.Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.Proc Natl Acad Sci U S A. 2001;98:13960-13965.
[21]Cenci S, Weitzmann MN, Roggia C, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.J Clin Invest.2000;106:1229-1237.
[22]Lee SK, Kadono Y, Okada F, et al. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy.J Bone Miner Res. 2006;21:1704-1712.
[23]Sass DA,Liss T,Bowman AR,et al.The role of the T-lymphocyte in estrogen deficiency osteopenia.J Bone Miner Res. 1997;12: 479-486.
[24]Komm BS, Terpening CM, Benz DJ, et al.Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.Science. 1988;241:81-84.
[25]Gao B, Huang Q, Lin YS, et al.Dose-dependent effect of estrogen suppresses the osteo-adipogenic transdifferentiation of osteoblasts via canonical Wnt signaling pathway.PLoS One. 2014;9:e99137.
[26]Qiu X, Jin X, Shao Z, et al.17beta-estradiol induces the proliferation of hematopoietic stem cells by promoting the osteogenic differentiation of mesenchymal stem cells.Tohoku J Exp Med.2014;233:141-148.
[27]Kousteni S, Bellido T, Plotkin LI, et al.Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity.Cell. 2001; 104:719-730.
[28]Kousteni S,Han L,Chen JR,et al.Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids.J Clin Invest. 2003;111:1651-1664.
[29]Pantschenko AG,Zhang W,Nahounou M,et al.Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.J Bone Miner Res.2005; 20:1414-1429.
[30]Gu G, Hentunen TA, Nars M, et al. Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis. 2005;10:583-595.
[31]Cooper LF,Tiffee JC,Griffin JP,et al.Estrogen-induced resistance to osteoblast apoptosis is associated with increased hsp27 expression.J Cell Physiol. 2000;185:401-7.
[32]Spelsberg TC, Subramaniam M, Riggs BL, et al. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton.Mol Endocrinol. 1999;13:819-828.
[33]Qu Q, Perala-Heape M, Kapanen A, et al. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone. 1998;22:201-209.
[34]de Faria AN, Zancanela DC, Ramos AP, et al. Estrogen and phenol red free medium for osteoblast culture: study of the mineralization ability.Cytotechnology. 2015. [Epub ahead of print]
[35]White J, Wilson G, Tucci MA, et al. The effects of sustained delivery of estrogen on bone strength and cardiovascular panels in osteoporotic female rats.Biomed Sci Instrum. 2014; 50:336-344.
[36]Shapiro LF,Freeman K. The relationship between estrogen, estrogen receptors and periodontal disease in adult women.J Mich Dent Assoc. 2014;96:40-44.
[37]Tang WR, Liu Y, Li LH, et al. [Fluid shear stress and raloxifene stimulates the proliferation of osteoblast through regulating the expresstion of beta-catenin and estrogen receptor alpha].Sichuan Da Xue Xue Bao Yi Xue Ban. 2014;45: 913-918.
[38]Chow SK, Leung KS, Qin L, et al. Callus formation is related to the expression ratios of estrogen receptors-alpha and -beta in ovariectomy-induced osteoporotic fracture healing.Arch Orthop Trauma Surg.2014;134:1405-1416.
[39]Henning P, Ohlsson C, Engdahl C, et al. The effect of estrogen on bone requires ERalpha in nonhematopoietic cells but is enhanced by ERalpha in hematopoietic cells.Am J Physiol Endocrinol Metab. 2014;307:E589-595.
[40]Almeida MQ, Tsang KM, Cheadle C, et al. Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: a link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors.Hum Mol Genet.2011;20: 165-175.
[41]Lindberg MK, Alatalo SL, Halleen JM, et al. Estrogen receptor specificity in the regulation of the skeleton in female mice.J Endocrinol. 2001;171:229-236.
[42]Chang J, Wang Z, Tang E, et al. Inhibition of osteoblastic bone formation by nuclear factor-kappaB.Nat Med. 2009;15: 682-689.
[43]Yamaguchi M,Weitzmann MN. The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity.Int J Mol Med. 2009;23: 297-301.
[44]Li Y, Li A, Strait K, et al. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.J Bone Miner Res. 2007;22: 646-655.
[45]Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids.J Biol Chem. 2007;282:27285-27297.
[46]Eliseev RA, Schwarz EM, Zuscik MJ, et al. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.Exp Cell Res. 2006;312:40-50.
[47]Finkel T,Holbrook NJ.Oxidants, oxidative stress and the biology of ageing.Nature. 2000;408:239-247.
[48]Manolagas SC,Almeida M. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol. 2007;21:2605-2614. |